194 related articles for article (PubMed ID: 21455325)
1. Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.
Vogl TJ; Nour-Eldin NE; Emad-Eldin S; Naguib NN; Trojan J; Ackermann H; Abdelaziz O
World J Gastroenterol; 2011 Mar; 17(10):1267-75. PubMed ID: 21455325
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
Silva JP; Berger NG; Tsai S; Christians KK; Clarke CN; Mogal H; White S; Rilling W; Gamblin TC
HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
[TBL] [Abstract][Full Text] [Related]
3. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
4. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
[TBL] [Abstract][Full Text] [Related]
5. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
Long J; Zheng JS; Sun B; Lu N
Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
[TBL] [Abstract][Full Text] [Related]
9. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.
Oliveira Ribeiro MC; Moda KA; Alvarez M; Koga KH; Moriguchi SM; Carvalho FC; Pinheiro RSN; Qi X; Romeiro FG
Acad Radiol; 2024 May; 31(5):1839-1848. PubMed ID: 38016824
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
[TBL] [Abstract][Full Text] [Related]
11. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
Hui TC; Pua U
J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein.
Kim JH; Shim JH; Yoon HK; Ko HK; Kim JW; Gwon DI
Liver Int; 2018 Sep; 38(9):1646-1654. PubMed ID: 29436101
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
15. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
Abdella H; Shaker MK; Montasser IF; Sobhi M; Aly H; Sayed A; Saleh S; El Dorry A
Indian J Gastroenterol; 2018 Mar; 37(2):127-132. PubMed ID: 29532323
[TBL] [Abstract][Full Text] [Related]
16. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study.
Chen J; Lai L; Luo J; Wang H; Li M; Huang M
BMC Cancer; 2022 Nov; 22(1):1242. PubMed ID: 36451104
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival.
Han K; Kim JH; Yoon HM; Kim EJ; Gwon DI; Ko GY; Yoon HK; Ko HK
Korean J Radiol; 2014; 15(4):464-71. PubMed ID: 25053906
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
Georgiades CS; Hong K; D'Angelo M; Geschwind JF
J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
